MITO Annual Total Long Term Liabilities
$84.69 M
+$59.52 M+236.47%
31 December 2021
Summary:
As of January 24, 2025, MITO annual total long term liabilities is $84.69 million, with the most recent change of +$59.52 million (+236.47%) on December 31, 2021. During the last 3 years, it has fallen by -$276.93 million (-76.58%).MITO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MITO Quarterly Long Term Liabilities
$79.34 M
-$5.35 M-6.32%
31 March 2022
Summary:
As of January 24, 2025, MITO quarterly total long term liabilities is $79.34 million, with the most recent change of -$5.35 million (-6.32%) on March 31, 2022. Over the past year, it has increased by +$48.69 million (+158.83%).MITO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MITO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +236.5% | +158.8% |
| 3 y3 years | -76.6% | +537.0% |
| 5 y5 years | -69.1% | -71.0% |
MITO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -76.6% | -78.1% |
Stealth BioTherapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $79.34 M(-6.3%) |
| Dec 2021 | $84.69 M(+236.5%) | $84.69 M(+33.7%) |
| Sept 2021 | - | $63.36 M(+40.3%) |
| June 2021 | - | $45.16 M(+47.3%) |
| Mar 2021 | - | $30.65 M(+21.8%) |
| Dec 2020 | $25.17 M | $25.17 M(>+9900.0%) |
| Sept 2020 | - | $0.00(0.0%) |
| June 2020 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $1.53 M(-99.6%) | $1.53 M(-81.2%) |
| Sept 2019 | - | $8.10 M(-21.6%) |
| June 2019 | - | $10.33 M(-17.1%) |
| Mar 2019 | - | $12.46 M(-96.6%) |
| Dec 2018 | $361.62 M(+32.1%) | $361.62 M(+2713.3%) |
| Sept 2018 | - | $12.85 M(-95.3%) |
| Dec 2017 | $273.85 M(+29.6%) | $273.85 M |
| Dec 2016 | $211.38 M | - |
FAQ
- What is Stealth BioTherapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Stealth BioTherapeutics?
- What is Stealth BioTherapeutics annual total long term liabilities year-on-year change?
- What is Stealth BioTherapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Stealth BioTherapeutics?
- What is Stealth BioTherapeutics quarterly long term liabilities year-on-year change?
What is Stealth BioTherapeutics annual total long term liabilities?
The current annual total long term liabilities of MITO is $84.69 M
What is the all time high annual total long term liabilities for Stealth BioTherapeutics?
Stealth BioTherapeutics all-time high annual total long term liabilities is $361.62 M
What is Stealth BioTherapeutics annual total long term liabilities year-on-year change?
Over the past year, MITO annual total long term liabilities has changed by +$59.52 M (+236.47%)
What is Stealth BioTherapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of MITO is $79.34 M
What is the all time high quarterly long term liabilities for Stealth BioTherapeutics?
Stealth BioTherapeutics all-time high quarterly total long term liabilities is $361.62 M
What is Stealth BioTherapeutics quarterly long term liabilities year-on-year change?
Over the past year, MITO quarterly total long term liabilities has changed by +$48.69 M (+158.83%)